• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[29例肺毛霉病手术及非手术治疗的临床特征]

[Clinical characteristics of 29 cases of pulmonary mucormycosis treated with and without surgery].

作者信息

Liu Z B, Zhang F, Liang C Y, Chen W H, Wang Y M, Cui X J, Zhao L, Cao B

机构信息

Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.

Department of Gerontology, Shijiazhuang People's Hospital, Shijiazhuang 050011, China.

出版信息

Zhonghua Jie He He Hu Xi Za Zhi. 2024 Oct 12;47(10):946-954. doi: 10.3760/cma.j.cn112147-20240426-00223.

DOI:10.3760/cma.j.cn112147-20240426-00223
PMID:39406541
Abstract

To analyze the clinical characteristics of patients with pulmonary mucormycosis treated with and without surgery. This was a single-center, retrospective study. We retrieved "pulmonary mucormycosis" from the electronic medical records of China-Japan Friendship Hospital between 2016 and 2022. A total of 29 patients with pulmonary mucormycosis were collected. There were 19 males and 10 females with a median age of 49 (47, 67) years. Mann-Whitney test, χ² test, Kaplan-Meier curve and log-rank test were used to compare the differences between groups. The most common underlying disease was diabetes (19, 65.5%). The most frequent imaging findings were consolidation (25, 86.2%) and nodule or mass (21, 72.4%). Bronchial stenosis (16, 55.2%), obstruction by fungal plugs (18, 62.1%), pseudomembranous necrotizing bronchitis (19, 65.5%) were common. Treatment strategies were developed by the multi-disciplinary team (MDT). Among 16 patients who did not undergo surgery, 10 had bilateral multifocal lesions and 6 had unifocal lesions. All patients received antifungal therapies, and surgeries were performed in 13 (44.8%) patients. Patients who underwent surgery had numerically lower in-hospital mortality (15.4% 31.3%, =0.410). Involvement of unilateral multiple lesions was more common in patients who underwent surgeries (6/13 1/16, =0.019). Patients who underwent surgery were more likely to have lobar and segmental bronchial involvement (13/13 9/16, =0.007). A total of 15 patients underwent mNGS, 14 (93.3%) had positive results. Performing metagenomic next generation sequencing for diagnosis shortened the time from disease onset to diagnosis (log-rank =0.014). Metagenomic next-generation sequencing aided early diagnosis. The patients who underwent surgery included unilateral multiple lesions and visualisation of endobronchial abnormalities on lobar or segmental bronchus in unilateral lung.

摘要

分析接受手术和未接受手术治疗的肺毛霉病患者的临床特征。这是一项单中心回顾性研究。我们从2016年至2022年中日友好医院的电子病历中检索“肺毛霉病”。共收集到29例肺毛霉病患者。其中男性19例,女性10例,中位年龄为49(47,67)岁。采用曼-惠特尼检验、χ²检验、Kaplan-Meier曲线和对数秩检验比较组间差异。最常见的基础疾病是糖尿病(19例,65.5%)。最常见的影像学表现为实变(25例,86.2%)和结节或肿块(21例,72.4%)。支气管狭窄(16例,55.2%)、真菌栓阻塞(18例,62.1%)、假膜性坏死性支气管炎(19例,65.5%)较为常见。治疗策略由多学科团队(MDT)制定。在16例未接受手术的患者中,10例为双侧多灶性病变,6例为单灶性病变。所有患者均接受抗真菌治疗,13例(44.8%)患者接受了手术。接受手术的患者院内死亡率在数值上较低(15.4%对31.3%,P = 0.410)。单侧多灶性病变在接受手术的患者中更为常见(6/13对1/16,P = 0.019)。接受手术的患者更易出现叶和段支气管受累(13/13对9/16,P = 0.007)。共有15例患者接受了宏基因组下一代测序(mNGS),14例(93.3%)结果为阳性。进行宏基因组下一代测序诊断缩短了从发病到诊断的时间(对数秩P = 0.014)。宏基因组下一代测序有助于早期诊断。接受手术的患者包括单侧多灶性病变以及单侧肺叶或段支气管内支气管异常的可视化。

相似文献

1
[Clinical characteristics of 29 cases of pulmonary mucormycosis treated with and without surgery].[29例肺毛霉病手术及非手术治疗的临床特征]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Oct 12;47(10):946-954. doi: 10.3760/cma.j.cn112147-20240426-00223.
2
Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome.肺部毛霉菌病的特征及预后的预测性风险因素。
Infection. 2018 Aug;46(4):503-512. doi: 10.1007/s15010-018-1149-x. Epub 2018 May 10.
3
[Pulmonary mucormycosis: report of 5 cases and review of 46 cases reported in China].[肺毛霉病:5例报告并复习国内46例报道]
Zhonghua Jie He He Hu Xi Za Zhi. 2013 Aug;36(8):572-6.
4
Pulmonary mucormycosis mimicking an endobronchial mass.酷似支气管内肿物的肺毛霉菌病
Asian Cardiovasc Thorac Ann. 2018 Mar;26(3):242-244. doi: 10.1177/0218492318760711. Epub 2018 Feb 15.
5
Clinical Characteristics, Prognosis Factors and Metagenomic Next-Generation Sequencing Diagnosis of Mucormycosis in patients With Hematologic Diseases.血液病患者毛霉菌病的临床特征、预后因素和宏基因组下一代测序诊断。
Mycopathologia. 2024 Aug 1;189(4):71. doi: 10.1007/s11046-024-00875-w.
6
Clinical Analysis of Diabetic Combined Pulmonary Mucormycosis.糖尿病合并肺毛霉菌病的临床分析。
Mycopathologia. 2017 Dec;182(11-12):1111-1117. doi: 10.1007/s11046-017-0167-z. Epub 2017 Jun 30.
7
Cut it out! Thoracic surgeon's approach to pulmonary mucormycosis and the role of surgical resection in survival.切除它!胸外科医生治疗肺毛霉菌病的方法以及手术切除对生存的作用。
Mycoses. 2019 Oct;62(10):893-907. doi: 10.1111/myc.12954. Epub 2019 Aug 6.
8
Pulmonary Mucormycosis as the Leading Clinical Type of Mucormycosis in Western China.中国西部地区肺毛霉病为毛霉病的主要临床类型。
Front Cell Infect Microbiol. 2021 Nov 22;11:770551. doi: 10.3389/fcimb.2021.770551. eCollection 2021.
9
[Clinical Characteristics and Prognosis of Patients with Acute Leukemia Complicated with Mucormycosis after Chemotherapy].[化疗后急性白血病合并毛霉菌病患者的临床特征及预后]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Jun;32(3):685-692. doi: 10.19746/j.cnki.issn.1009-2137.2024.03.006.
10
Medical ablation of endobronchial mucormycosis with Amphotericin-B.两性霉素B对支气管内毛霉菌病的医学消融治疗
J Assoc Physicians India. 2007 Dec;55:861-5.